CompletedPhase 2NCT03101111

Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area

Studying Chikungunya

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Themis Bioscience GmbH
Principal Investigator
Clemente Diaz, MD
University of Puerto Rico
Intervention
MV-CHIK(biological)
Enrollment
34 enrolled
Eligibility
21-50 years · All sexes
Timeline
2017 – 2019

Study locations (1)

Collaborators

Walter Reed Army Institute of Research (WRAIR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03101111 on ClinicalTrials.gov

Other trials for Chikungunya

Additional recruiting or active studies for the same condition.

See all trials for Chikungunya →

← Back to all trials